SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+13.25%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$731M
AUM Growth
+$731M
(+5.8%)
Cap. Flow
+$30.8M
Cap. Flow
% of AUM
4.21%
Top 10 Holdings %
Top 10 Hldgs %
42.41%
Holding
130
New
31
Increased
26
Reduced
26
Closed
31
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$37M |
| 2 |
Novo Nordisk
NVO
|
$20.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
$11.9M |
| 4 |
UroGen Pharma
URGN
|
$11.4M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$11.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$20.3M |
| 2 |
Viatris
VTRS
|
$19.1M |
| 3 |
Ituran Location and Control
ITRN
|
$14.6M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$11.9M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$10.2M |
Sector Composition
| 1 | Healthcare | 82.83% |
| 2 | Technology | 9.84% |
| 3 | Consumer Discretionary | 1.78% |
| 4 | Industrials | 1.62% |
| 5 | Communication Services | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
AC Immune
ACIU
$205M
| – | – | -310,613 | Closed | -$2.94M |
|
127
Adverum Biotechnologies
ADVM
$64.6M
| – | – | -63,355 | Closed | -$200K |
|
|
EPZM
128
DELISTED
Epizyme, Inc
EPZM
| – | – | -749,502 | Closed | -$4.62M |
|
|
SRRA
129
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| – | – | -258,510 | Closed | -$341K |
|